Shares of Proteome Sciences plc (LON:PRM – Get Free Report) were down 9.8% during trading on Wednesday . The stock traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). Approximately 41,420 shares were traded during trading, a decline of 55% from the average daily volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Trading Down 9.8 %
The company has a market cap of £9.37 million, a PE ratio of -317.50 and a beta of 0.07. The business’s 50 day moving average is GBX 2.90 and its two-hundred day moving average is GBX 3.12.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- How to Short a Stock in 5 Easy Steps
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- When to Sell a Stock for Profit or Loss
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
